Online inquiry

IVTScrip™ mRNA-Human ASB9, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28701MR)

This product GTTS-WK28701MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ASB9 protein. This product can be used in Retinoid acid signaling-responsive fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001031739.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 140462
UniProt ID Q96DX5
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ASB9, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28701MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK9005MR IVTScrip™ mRNA-Human 3C4, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA 3C4
GTTS-WK28638MR IVTScrip™ mRNA-Human ARL17A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARL17A
GTTS-WK23213MR IVTScrip™ mRNA-Human ARHGEF2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF2
GTTS-WK15633MR IVTScrip™ mRNA-Human AIM1, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AIM1
GTTS-WK18509MR IVTScrip™ mRNA-Human ANKRD20A8P, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANKRD20A8P
GTTS-WK19799MR IVTScrip™ mRNA-Human APBB1IP, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA APBB1IP
GTTS-WK0778MR IVTScrip™ mRNA-Human WNT4, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA WNT4
GTTS-WK26405MR IVTScrip™ mRNA-Human Apelin, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA Apelin
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW